PSA is a validated FDA-recognized clinical endpoint in assessing prostate cancer treatment response; Telomir-1 lowered PSA levels in a dose-related manner. MIAMI, FLORIDA / ACCESS Newswire / November ...

Webinar to be held Tuesday, December 2nd, at 8:00 am ETREDWOOD CITY, Calif., Dec. 01, 2025 (GLOBE NEWSWIRE) -- Jasper ...

In July, the FDA refused to approve Capricor’s application for Deramiocel for the treatment of cardiomyopathy associated with ...

Founder, Chief Science Officer and Executive Chairman, Longeveron Results obtained in the Phase 2 placebo-controlled ...

San Diego-based Protego Biopharma, a biotech developing small molecule therapeutics that reprogram protein folding to address ...

Scientists have found that common foods can contain hidden contaminants formed during cooking or through environmental ...

New analyses from the ongoing open label extension (OLE) studies and findings from electroencephalogram (EEG) assessments in ...

USA: A recent retrospective study published in the Journal of Periodontology has offered new insights into the long-debated question of whether saving a natural tooth through periodontal regeneration ...

The breakthrough addresses a longstanding challenge. Researchers make remarkable breakthrough that could transform common ...

Based on Stoke Therapeutics’ preliminary estimates, which scaled annual incidence to prevalence using country-specific live birth rates over the past 85 years and adjusted for Dravet-specific ...

The fireside chat will be held at 3:25pm Eastern Time and a live webcast of the presentation may be accessed by visiting the Events page of the Company’s website at www.promisneurosciences.com. The ...

The identification of the remains was based on a contemporary osteological analysis, but they were subsequently lost and only ...